Abstract
By driving the ongoing pandemic of coronavirus disease 2019 (COVID-19), coronaviruses have become a significant change in twenty-first-century medicine, healthcare systems, education, and the global economy. This chapter rapidly reviews the origin, immunopathogenesis, epidemiology, diagnosis, clinical manifestations, and potential therapeutics of COVID-19. It would also explore the effects of the introduction of a single virus, the so-called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), on the public health preparedness planning.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdullah AS, Tomlinson B, Cockram CS, Thomas GN (2003) Lessons from the severe acute respiratory syndrome outbreak in Hong Kong. Emerg Infect Dis 9(9):1042
Açikgöz Ö, Günay A (2020) The early impact of the Covid-19 pandemic on the global and Turkish economy. Turk J Med Sci 50(SI-1):520–526. https://doi.org/10.3906/sag-2004-6
Ahmadi M, Saffarzadeh N, Habibi MA, Hajiesmaeili F, Rezaei N (2020, Jann 1) Colon cancer and SARS-CoV-2: impact of ACE2 expression in susceptibility to COVID-19. bioRxiv
Ahmed W, Angel N, Edson J, Bibby K, Bivins A, O’Brien JW, Choi PM, Kitajima M, Simpson SL, Li J (2020) First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: a proof of concept for the wastewater surveillance of COVID-19 in the community. Sci Total Environ 728:138764
Anyane-Yeboa A, Sato T, Sakuraba A (2020) Racial disparities in COVID-19 deaths reveal harsh truths about structural inequality in america. J Intern Med 288:479. https://doi.org/10.1111/joim.13117
Ather A, Patel B, Ruparel NB, Diogenes A, Hargreaves KM (2020) Coronavirus disease 19 (COVID-19): implications for clinical dental care. J Endod 46(5):584–595. https://doi.org/10.1016/j.joen.2020.03.008
Babaha F, Rezaei N (2020) Primary immunodeficiency diseases in COVID-19 pandemic: a predisposing or protective factor? Am J Med Sci. https://doi.org/10.1016/j.amjms.2020.07.027
Bahrami A, Vafapour M, Moazzami B, Rezaei N (2020, Jul 8) Hyperinflammatory shock related to COVID‐19 in a patient presenting with multisystem inflammatory syndrome in children: first case from Iran. J Paediatr Child Health
Banerjee D (2020) ‘Age and ageism in COVID-19’: elderly mental health-care vulnerabilities and needs. Asian J Psychiatr 51:102154. https://doi.org/10.1016/j.ajp.2020.102154
Basiri A, Heidari A, Nadi MF, Fallahy MTP, Nezamabadi SS, Sedighi M, Saghazadeh A, Rezaei N (2020a) Microfluidic devices for detection of RNA viruses. Rev Med Virol n/a (n/a):e2154. https://doi.org/10.1002/rmv.2154
Basiri A, Pazhouhnia Z, Beheshtizadeh N, Hoseinpour M, Saghazadeh A, Rezaei N (2020b, Jun 20) Regenerative medicine in COVID-19 treatment: real opportunities and range of promises. Stem Cell Rev Rep 20:1–13
Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, Liu X, Wei L, Truelove SA, Zhang T, Gao W, Cheng C, Tang X, Wu X, Wu Y, Sun B, Huang S, Sun Y, Zhang J, Ma T, Lessler J, Feng T (2020) Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis 20:911. https://doi.org/10.1016/S1473-3099(20)30287-5
Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ (2020) The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 395:912
Bulut C, Kato Y (2020) Epidemiology of COVID-19. Turk J Med Sci 50(SI-1):563–570. https://doi.org/10.3906/sag-2004-172
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C (2020) A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 382(19):1787–1799. https://doi.org/10.1056/NEJMoa2001282
Cheema M, Aghazadeh H, Nazarali S, Ting A, Hodges J, McFarlane A, Kanji JN, Zelyas N, Damji KF, Solarte C (2020) Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol 55:e125. https://doi.org/10.1016/j.jcjo.2020.03.003
Chen L, Xiong J, Bao L, Shi Y (2020) Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 20(4):398–400. https://doi.org/10.1016/S1473-3099(20)30141-9
Cherry JD (2004) The chronology of the 2002–2003 SARS mini pandemic. Paediatr Respir Rev 5(4):262–269
Chow KYC, Hon CC, Hui RKH, Wong RTY, Yip CW, Zeng F, Leung FCC (2003) Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Genomics Proteomics Bioinformatics 1(4):247–262
Clem AS (2011) Fundamentals of vaccine immunology. J Global Infect Dis 3(1):73–78. https://doi.org/10.4103/0974-777X.77299
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, Bleicker T, Brünink S, Schneider J, Schmidt ML (2020) Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance 25(3):2000045
Cowling BJ, Leung GM (2020) Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak. Eurosurveillance 25(6):2000110
Craven J (2020, May 28) COVID-19 vaccine tracker. https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker
Darbeheshti F, Rezaei N (2020) Genetic predisposition models to COVID-19 infection. Med Hypotheses 142:109818
Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, Chen L, Li M, Liu Y, Wang G (2020) Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 11:827
Doraiswamy S, Cheema S, Mamtani R (2020) Older people and epidemics: a call for empathy. Age Ageing 49(3):493–493
Dowell SF, Ho MS (2004) Seasonality of infectious diseases and severe acute respiratory syndrome-what we don’t know can hurt us. Lancet Infect Dis 4(11):704–708. https://doi.org/10.1016/S1473-3099(04)01177-6
Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, Lahiri D, Lavie CJ (2020) Psychosocial impact of COVID-19. Diabetes Metab Syndr 14:779. https://doi.org/10.1016/j.dsx.2020.05.035
Fan EX (2003) SARS: economic impacts and implications. Asian Development Bank, Manila
Fathi N, Rezaei N (2020) Lymphopenia in COVID-19: therapeutic opportunities. Cell Biol Int 44:1792
Faye O, Faye O, Dupressoir A, Weidmann M, Ndiaye M, Sall AA (2008) One-step RT-PCR for detection of Zika virus. J Clin Virol 43(1):96–101
Fernandes N (2020) Economic effects of coronavirus outbreak (COVID-19) on the World Economy SSRN: https://ssrn.com/abstract=3557504 or https://doi.org/10.2139/ssrn.3557504
Fintelman-Rodrigues N, Sacramento CQ, Lima CR, da Silva FS, Ferreira A, Mattos M, de Freitas CS, Soares VC, Dias SD, Temerozo JR, Miranda M (2020, Jan 1) Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production. bioRxiv
Gandhi M, Yokoe DS, Havlir DV (2020) Asymptomatic transmission, the Achilles’ heel of current strategies to control Covid-19. N Engl J Med 382(22):2158–2160. https://doi.org/10.1056/NEJMe2009758
Ghosh R, Dubey MJ, Chatterjee S, Dubey S (2020) Impact of COVID-19 on children: special focus on psychosocial aspect. Education 31:34
Goscé L, Phillips PA, Spinola P, Gupta DRK, Abubakar PI (2020) Modelling SARS-COV2 spread in London: approaches to lift the lockdown. J Infect 81:260. https://doi.org/10.1016/j.jinf.2020.05.037
Gralinski LE, Menachery VD (2020) Return of the coronavirus: 2019-nCoV. Viruses 12(2):135. https://doi.org/10.3390/v12020135
Gu J, Han B, Wang J (2020) COVID-19: gastrointestinal manifestations and potential fecal–oral transmission. Gastroenterology 158(6):1518–1519
Guan W-j, Liang W-h, Zhao Y, Liang H-r, Chen Z-s, Li Y-m, Liu X-q, Chen R-c, Tang C-l, Wang T, Ou C-q, Li L, Chen P-y, Sang L, Wang W, Li J-f, Li C-c, Ou L-m, Cheng B, Xiong S, Ni Z-y, Xiang J, Hu Y, Liu L, Shan H, Lei C-l, Peng Y-x, Wei L, Liu Y, Hu Y-h, Peng P, Wang J-m, Liu J-y, Chen Z, Li G, Zheng Z-j, Qiu S-q, Luo J, Ye C-j, Zhu S-y, Cheng L-l, Ye F, Li S-y, Zheng J-p, Zhang N-f, Zhong N-s, He J-x (2020a) Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 55(5):2000547. https://doi.org/10.1183/13993003.00547-2020
Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, Liu L, Shan H, Lei C-l, Hui DSC, Du B, Li L-j, Zeng G, Yuen K-Y, Chen R-c, Tang C-l, Wang T, Chen P-y, Xiang J, Li S-y, Wang J-l, Liang Z-j, Peng Y-x, Wei L, Liu Y, Hu Y-h, Peng P, Wang J-m, Liu J-y, Chen Z, Li G, Zheng Z-j, Qiu S-q, Luo J, Ye C-j, Zhu S-y, Zhong N-s (2020b) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720. https://doi.org/10.1056/NEJMoa2002032
Han R, Huang L, Jiang H, Dong J, Peng H, Zhang D (2020) Early clinical and CT manifestations of coronavirus disease 2019 (COVID-19) pneumonia. Am J Roentgenol 215:1–6. https://doi.org/10.2214/AJR.20.22961
Hanaei S, Rezaei N (2020) COVID-19: developing from an outbreak to a pandemic. Arch Med Res 51:582
Helmy YA, Fawzy M, Elaswad A, Sobieh A, Kenney SP, Shehata AA (2020) The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control. J Clin Med 9(4):1225. https://doi.org/10.3390/jcm9041225
Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, Caricchio R, Mahmud S, Hazen MM, Halyabar O (2020) On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheum 72:1059
Hessami A, Shamshirian A, Heydari K, Pourali F, Alizadeh-Navaei R, Moosazadeh M, Abrotan S, Shojaei L, Sedighi S, Shamshirian D, Rezaei N (2020, Oct 16) Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis. Am J Emerg Med
Hirbod-Mobarakeh A, Mahmoudi M, Rezaei N (2014) Nutrition, immunity, and aging. In: Immunology of aging. Springer, Berlin, pp 263–284
Hiscott J, Alexandridi M, Muscolini M, Tassone E, Palermo E, Soultsioti M, Zevini A (2020) The global impact of the coronavirus pandemic. Cytokine Growth Factor Rev 53:1. https://doi.org/10.1016/j.cytogfr.2020.05.010
Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, Wu Y, Sun L, Xu Y (2020) Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Virol 127:104371
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020a) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London) 395(10223):497–506. https://doi.org/10.1016/s0140-6736(20)30183-5
Huang X, Wei F, Hu L, Wen L, Chen K (2020b) Epidemiology and clinical characteristics of COVID-19. Arch Iran Med March 23(4):268–271. https://doi.org/10.34172/aim.2020.09
Hung IF-N, Lung K-C, Tso EY-K, Liu R, Chung TW-H, Chu M-Y, Ng Y-Y, Lo J, Chan J, Tam AR, Shum H-P, Chan V, Wu AK-L, Sin K-M, Leung W-S, Law W-L, Lung DC, Sin S, Yeung P, Yip CC-Y, Zhang RR, Fung AY-F, Yan EY-W, Leung K-H, Ip JD, Chu AW-H, Chan W-M, Ng AC-K, Lee R, Fung K, Yeung A, Wu T-C, Chan JW-M, Yan W-W, Chan W-M, Chan JF-W, Lie AK-W, Tsang OT-Y, Cheng VC-C, Que T-L, Lau C-S, Chan K-H, To KK-W, Yuen K-Y (2020) Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet 395(10238):1695–1704. https://doi.org/10.1016/S0140-6736(20)31042-4
Jabbari P, Rezaei N (2020) With risk of reinfection, is COVID-19 here to stay? Disaster Med Public Health Prep:1. https://doi.org/10.1017/dmp.2020.274
Jabbari P, Jabbari F, Ebrahimi S, Rezaei N (2020, Jun) COVID-19: a chimera of two pandemics. Disaster Med Public Health Prep 14(3):e38–9
Jahanshahlu L, Rezaei N (2020a) Central nervous system involvement in COVID-19. Arch Med Res 51:721
Jahanshahlu L, Rezaei N (2020b) Monoclonal antibody as a potential anti-COVID-19. Biomed Pharmacother 129:110337
Jeong H, Yim HW, Song Y-J, Ki M, Min J-A, Cho J, Chae J-H (2016) Mental health status of people isolated due to middle east respiratory syndrome. Epidemiol Health 38:e2016048
Kim JY, Choe PG, Oh Y, Oh KJ, Kim J, Park SJ, Park JH, Na HK, Oh M-d (2020) The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. J Korean Med Sci 35(5):e61
Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, Wu J, Du H, Chen T, Li R (2020) Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open 3(3):e203976–e203976
Lau JT, Tsui H, Lau M, Yang X (2004) SARS transmission, risk factors, and prevention in Hong Kong. Emerg Infect Dis 10(4):587
Leung K, Wu JT, Liu D, Leung GM (2020) First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment. Lancet 395(10233):1382–1393. https://doi.org/10.1016/S0140-6736(20)30746-7
Li J-Y, You Z, Wang Q, Zhou Z-J, Qiu Y, Luo R, Ge X-Y (2020a) The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes Infect 22(2):80–85. https://doi.org/10.1016/j.micinf.2020.02.002
Li X, Geng M, Peng Y, Meng L, Lu S (2020b) Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 10(2):102–108. https://doi.org/10.1016/j.jpha.2020.03.001
Lipsitch M, Swerdlow DL, Finelli L (2020) Defining the epidemiology of Covid-19—studies needed. N Engl J Med 382(13):1194–1196
Liu P, Jiang J-Z, Wan X-F, Hua Y, Li L, Zhou J, Wang X, Hou F, Chen J, Zou J, Chen J (2020a) Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? PLoS Pathog 16(5):e1008421. https://doi.org/10.1371/journal.ppat.1008421
Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H, Zhu J, Zhang Q, Wu J, Liu L (2020b) Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol 92:595. https://doi.org/10.1002/jmv.25726
Lotfi M, Rezaei N (2020) SARS-CoV-2: a comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol 92:1864
Lotfi M, Hamblin MR, Rezaei N (2020) COVID-19: transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta 508:254
Lovato A, de Filippis C (2020) Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms. Ear Nose Throat J 99:569.:0145561320920762. https://doi.org/10.1177/0145561320920762
Lu C-C, Chen M-Y, Chang Y-L (2020) Potential therapeutic agents against COVID-19: what we know so far. J Chin Med Assoc Latest Articles 83:534
Luan J, Lu Y, Jin X, Zhang L (2020) Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection. Biochem Biophys Res Commun 526(1):165–169. https://doi.org/10.1016/j.bbrc.2020.03.047
Luo W, Yu H, Gou J, Li X, Sun Y, Li J, Liu L (2020) Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Preprints 2020:2020020407
Lurie N, Saville M, Hatchett R, Halton J (2020) Developing Covid-19 vaccines at pandemic speed. N Engl J Med 382(21):1969–1973. https://doi.org/10.1056/NEJMp2005630
Mahmoudi M, Rezaei N (2019) Nutrition and immunity. Springer, Cham
Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N (2020) The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19. Life Sci 258:118185. https://doi.org/10.1016/j.lfs.2020.118185
Masters PS (2006) The molecular biology of coronaviruses. Adv Virus Res 66:193–292
McKee M, Stuckler D (2020) If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future. Nat Med 26(5):640–642. https://doi.org/10.1038/s41591-020-0863-y
medicine USnlo (2020a) BCG vaccination to protect healthcare workers against COVID-19 (BRACE). https://clinicaltrials.gov/ct2/show/NCT04327206
medicine USnlo (2020b) Reducing health care workers absenteeism in Covid-19 pandemic through BCG vaccine (BCG-CORONA). https://clinicaltrials.gov/ct2/show/NCT04328441
Mehra MR, Desai SS, Ruschitzka F, Patel AN (2020) Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. https://doi.org/10.1016/S0140-6736(20)31180-6
Miller AM (2020) How you should prepare for a potential ‘second wave’ of the coronavirus, according to experts. Business Insider France. https://www.businessinsider.fr/graphique-du-jour-titres-les-plus-ecoutes-sur-spotify-2017. Accessed 25 May 2020
Mirbeyk M, Rezaei N (2020) The impact of COVID-19 on pregnancy and neonatal health: a systematic review
Moazzami B, Razavi-Khorasani N, Moghadam AD, Farokhi E, Rezaei N (2020) COVID-19 and telemedicine: immediate action required for maintaining healthcare providers Well-being. J Clin Virol 126:104345
Mohamed K, Rodríguez-Román E, Rahmani F, Zhang H, Ivanovska M, Makka SA, Joya M, Makuku R, Islam MS, Radwan N (2020a) Borderless collaboration is needed for COVID-19—a disease that knows no borders. Infect Control Hosp Epidemiol 41:1–2
Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N (2020b) Computational drug discovery and repurposing for the treatment of COVID-19: a systematic review. Bioinorg Chem 104490. https://doi.org/10.1016/j.bioorg.2020.104490
Momtazmanesh S, Ochs HD, Uddin LQ, Perc M, Routes JM, Vieira DN, Al-Herz W, Baris S, Prando C, Rosivall L (2020) All together to fight COVID-19. Am J Trop Med Hyg 102(6):1181–1183
Monto AS, DeJonge PM, Callear AP, Bazzi LA, Capriola SB, Malosh RE, Martin ET, Petrie JG (2020) Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan. J Infect Dis 222:9. https://doi.org/10.1093/infdis/jiaa161
Moradian N, Ochs HD, Sedikies C, Hamblin MR, Camargo CA, Martinez JA, Biamonte JD, Abdollahi M, Torres PJ, Nieto JJ (2020) The urgent need for integrated science to fight COVID-19 pandemic and beyond. J Transl Med 18(1):1–7
Nasab MG, Saghazadeh A, Rezaei N (2020) SARS-CoV-2-a tough opponent for the immune system. Arch Med Res 51:589. https://doi.org/10.1016/j.arcmed.2020.05.020
Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, Agha M, Agha R (2020) The socio-economic implications of the coronavirus and COVID-19 pandemic: a review. Int J Surg 78:185.:S1743-9191(1720)30316-30312. https://doi.org/10.1016/j.ijsu.2020.04.018
Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung S-M, Hayashi K, Kinoshita R, Yang Y, Yuan B, Akhmetzhanov AR, Linton NM (2020) Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis 94:154–155. https://doi.org/10.1016/j.ijid.2020.03.020
Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S (2020) Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol: J Mol Epidemiol Evol Genet Infect Dis 79:104212. https://doi.org/10.1016/j.meegid.2020.104212
Park M, Cook AR, Lim JT, Sun Y, Dickens BL (2020) A systematic review of COVID-19 epidemiology based on current evidence. J Clin Med 9(4):967
Pashaei M, Rezaei N (2020) Immunotherapy for SARS-CoV-2: potential opportunities. Expert Opin Biol Ther 20:1–5. https://doi.org/10.1080/14712598.2020.1807933
Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, Baghbanzadeh M, Aghamohammadi N, Zhang W, Haque U (2020) The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol 49:717
Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B (2020) Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci 12(1):1–6
Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E (2020) COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect 26:729
Podile AR, Basu A (2020) Opportunities, challenges and directions in science and technology for tackling COVID-19. Trans Indian Natl Acad Eng 5:1–5. https://doi.org/10.1007/s41403-020-00111-z
Pourahmad R, Moazzami B, Rezaei N (2020) Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19. SN Compr Clin Med 2:1407–1411. https://doi.org/10.1007/s42399-020-00438-2
Prompetchara E, Ketloy C, Palaga T (2020) Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol 38(1):1–9
Rabiee N, Rabiee M, Bagherzadeh M, Rezaei N (2020) COVID-19 and picotechnology: potential opportunities. Med Hypotheses 144:109917
Rashid ZZ, Othman SN, Samat MNA, Ali UK, Wong KK (2020) Diagnostic performance of COVID-19 serology assays. Malays J Pathol 42(1):13–21
Rezaei N (2020a) COVID-19 affects healthy pediatricians more than pediatric patients. Infect Control Hosp Epidemiol 41:1. https://doi.org/10.1017/ice.2020.139
Rezaei N (2020b) COVID-19 and medical biotechnology. Avicenna J Med Biotechnol 12(3):139
Richard Baldwin BWDM (2020, March 06) Economics in the time of COVID-19. A VoxEU.org Book, CEPR Press
Robertson E, Hershenfield K, Grace SL, Stewart DE (2004) The psychosocial effects of being quarantined following exposure to SARS: a qualitative study of Toronto health care workers. Can J Psychiatr 49(6):403–407
Rokni M, Hamblin MR, Rezaei N (2020) Cytokines and COVID-19: friends or foes? Hum Vaccin Immunother 16:1–3
Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W (2020) Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 382(10):970–971
Rubin GJ, Wessely S (2020) The psychological effects of quarantining a city. BMJ 368:m313
Rzymski P, Nowicki M, Mullin GE, Abraham A, Rodríguez-Román E, Petzold MB, Bendau A, Sahu KK, Ather A, Naviaux A-F (2020) Quantity does not equal quality: scientific principles cannot be sacrificed. Int Immunopharmacol 86:106711
Sabino-Silva R, Jardim ACG, Siqueira WL (2020) Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis. Clin Oral Investig 24(4):1619–1621
Saghazadeh A, Rezaei N (2017) Implications of toll-like receptors in Ebola infection. Expert Opin Ther Targets 21(4):415–425
Saghazadeh A, Rezaei N (2019) In: Rezaei N (ed) Introductory chapter: immunogenetics, immunogenetics. IntechOpen. https://doi.org/10.5772/intechopen.85505. Available from: https://www.intechopen.com/books/immunogenetics/introductory-chapter-immunogenetics
Saghazadeh A, Rezaei N (2020a) Immune-epidemiological parameters of the novel coronavirus – a perspective. Expert Rev Clin Immunol 16(5):465–470. https://doi.org/10.1080/1744666x.2020.1750954
Saghazadeh A, Rezaei N (2020b) Towards treatment planning of COVID-19: rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids. Int Immunopharmacol 84:106560. https://doi.org/10.1016/j.intimp.2020.106560
Sahu KK, Siddiqui AD, Rezaei N, Cerny J (2020) Challenges for management of immune thrombocytopenia during COVID-19 pandemic. J Med Virol 92:2277
Saleki K, Banazadeh M, Saghazadeh A, Rezaei N (2020) The involvement of the central nervous system in patients with COVID-19. Reviews in the Neurosciences 1, no. ahead-of-print
Sanchez E (2020) COVID-19 science: why testing is so important. American Heart Association. https://www.heart.org/en/news/2020/04/02/covid-19-science-why-testing-is-so-important. Accessed 25 May 2020
Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB (2020) Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA 323(18):1824–1836. https://doi.org/10.1001/jama.2020.6019
Shamshirian D, Rezaei N (2020) Cardiovascular diseases burden in COVID-19: systematic review and meta-analysis
Sharifkashani S, Bafrani MA, Khaboushan AS, Pirzadeh M, Kheirandish A, Yavarpour Bali H, Hessami A, Saghazadeh A, Rezaei N (2020) Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: potential therapeutic targeting. Eur J Pharmacol 884:173455. https://doi.org/10.1016/j.ejphar.2020.173455
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R (2020) COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res 24:91–98. https://doi.org/10.1016/j.jare.2020.03.005
Sim K, Chua HC (2004) The psychological impact of SARS: a matter of heart and mind. CMAJ 170(5):811–812
Skowronski DM, Astell C, Brunham RC, Low DE, Petric M, Roper RL, Talbot PJ, Tam T, Babiuk L (2005) Severe acute respiratory syndrome (SARS): a year in review. Annu Rev Med 56:357–381
Song P, Karako T (2020) COVID-19: real-time dissemination of scientific information to fight a public health emergency of international concern. Biosci Trends 14:1
Spinato G, Fabbris C, Polesel J, Cazzador D, Borsetto D, Hopkins C, Boscolo-Rizzo P (2020) Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA 323(20):2089–2090. https://doi.org/10.1001/jama.2020.6771
Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, Liu W, Bi Y, Gao GF (2016) Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 24(6):490–502. https://doi.org/10.1016/j.tim.2016.03.003
Su H, Yang M, Wan C, Yi L-X, Tang F, Zhu H-Y, Yi F, Yang H-C, Fogo AB, Nie X, Zhang C (2020) Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98(1):219–227. https://doi.org/10.1016/j.kint.2020.04.003
Sun LH (2020) CDC director warns second wave of coronavirus is likely to be even more devastating. The Washington Post. https://www.washingtonpost.com/health/2020/04/21/coronavirus-secondwave-cdcdirector/. Accessed 25 May 2020
Thanh Le T, Andreadakis Z, Kumar A, Gomez Roman R, Tollefsen S, Saville M, Mayhew S (2020) The COVID-19 vaccine development landscape. Nat Rev Drug Discov 19(5):305–306. https://doi.org/10.1038/d41573-020-00073-5
Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, Xiao S-Y (2020) Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol 33:1–8
Todd B (2020) Where are the masks? Am J Nurs 120(6):18–19. https://doi.org/10.1097/01.NAJ.0000668700.23009.1e
Verch T, Trausch JJ, Shank-Retzlaff M (2018) Principles of vaccine potency assays. Bioanalysis 10(3):163–180. https://doi.org/10.4155/bio-2017-0176
Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, Cuomo-Dannenburg G, Thompson H, Walker PGT, Fu H (2020) Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 20:669
Wang M, Yan M, Xu H, Liang W, Kan B, Zheng B, Chen H, Zheng H, Xu Y, Zhang E (2005) SARS-CoV infection in a restaurant from palm civet. Emerg Infect Dis 11(12):1860
Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C (2020) Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 395(10236):1569–1578. https://doi.org/10.1016/S0140-6736(20)31022-9
Wang F, Kream RM, Stefano GB (2020a) An evidence based perspective on mRNA-SARS-CoV-2 vaccine development. Med Sci Monit 26:e924700. https://doi.org/10.12659/msm.924700
Wang H-Y, Li X-L, Yan Z-R, Sun X-P, Han J, Zhang B-W (2020b) Potential neurological symptoms of COVID-19. Ther Adv Neurol Disord 13:1756286420917830. https://doi.org/10.1177/1756286420917830
Wang S, Wen X, Liu B, Dong Y, Cui M (2020c) Psychological influence of Coronovirus disease 2019 (COVID-19) pandemic on the general public, medical workers and patients with mental disorders and its countermeasures. Psychosomatics. https://doi.org/10.1016/j.psym.2020.05.005
Xiao K, Zhai J, Feng Y, Zhou N, Zhang X, Zou J-J, Li N, Guo Y, Li X, Shen X, Zhang Z, Shu F, Huang W, Li Y, Zhang Z, Chen R-A, Wu Y-J, Peng S-M, Huang M, Xie W-J, Cai Q-H, Hou F-H, Liu Y, Chen W, Xiao L, Shen Y (2020) Isolation and characterization of 2019-nCoV-like coronavirus from Malayan Pangolins. bioRxiv:2020.2002.2017.951335. https://doi.org/10.1101/2020.02.17.951335
Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J (2020a) Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology 296:E41. 200343
Xie Y, Cao S, Dong H, Li Q, Chen E, Zhang W, Yang L, Fu S, Wang R (2020b) Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19. J Infect:S0163–4453(0120)30172–30179. https://doi.org/10.1016/j.jinf.2020.03.044
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8(4):420–422
Yan Y, Shin WI, Pang YX, Meng Y, Lai J, You C, Zhao H, Lester E, Wu T, Pang CH (2020) The first 75 days of novel coronavirus (SARS-CoV-2) outbreak: recent advances, prevention, and treatment. Int J Environ Res Public Health 17(7):2323. https://doi.org/10.3390/ijerph17072323
Yang Y, Lu Q, Liu M, Wang Y, Zhang A, Jalali N, Dean N, Longini I, Halloran ME, Xu B, Zhang X (2020, Jan 1) Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. MedRxiv
Yao H, Chen J-H, Xu Y-F (2020) Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry 7(4):e21
Yazdanpanah F, Hamblin MR, Rezaei N (2020a) The immune system and COVID-19: friend or foe? Life Sci 256:117900. https://doi.org/10.1016/j.lfs.2020.117900
Yazdanpanah N, Saghazadeh A, Rezaei N (2020b) Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19). Rev Neurosci 31:691. https://doi.org/10.1515/revneuro-2020-0039
Ye Q, Wang B, Mao J (2020) The pathogenesis and treatment of theCytokine Storm’in COVID-19. J Infect 80(6):607–613
Yousefzadegan S, Rezaei N (2020) Case report: death due to COVID-19 in three brothers. Am J Trop Med Hyg 102(6):1203–1204
Yuan J, Hon C-C, Li Y, Wang D, Xu G, Zhang H, Zhou P, Poon LL, Lam TT-Y, Leung FC-C (2010) Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans. J Gen Virol 91(4):1058–1062
Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, Xu Y, Tian Z (2020a) Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol 17(5):533–535
Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X (2020b) COVID-19 and the cardiovascular system. Nat Rev Cardiol 17(5):259–260
Zhong NS, Zeng GQ (2008) Pandemic planning in China: applying lessons from severe acute respiratory syndrome. Respirology 13:S33–S35. https://doi.org/10.1111/j.1440-1843.2008.01255.x
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD (2020a) Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv. Cold Spring Harb Lab 2020:22–914952
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL (2020b) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270–273. https://doi.org/10.1038/s41586-020-2012-7
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rezaei, N. et al. (2021). Introduction on Coronavirus Disease (COVID-19) Pandemic: The Global Challenge. In: Rezaei, N. (eds) Coronavirus Disease - COVID-19. Advances in Experimental Medicine and Biology, vol 1318. Springer, Cham. https://doi.org/10.1007/978-3-030-63761-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-63761-3_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-63760-6
Online ISBN: 978-3-030-63761-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)